AUTH/2700/2/14: Nurse v Novartis — Gilenya advertisement in a lay publication (out of scope; no breach)

📅 2014 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2700/2/14
PartiesNurse v Novartis
ProductGilenya
IssueAdvertisement in a lay publication
Complaint received10 February 2014
Completed21 March 2014
Applicable Code year2012
DecisionNo breach; outwith the scope of the Code
Case reportNo case report (outwith scope)
SanctionsNone stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A nurse complained about a Gilenya advertisement appearing in a lay publication.
  • The complaint was received by the PMCPA on 10 February 2014.
  • The case was completed on 21 March 2014.
  • The PMCPA concluded the matter was outwith the scope of the ABPI Code (Applicable Code year: 2012).
  • No case report was issued because it was outwith scope.
⚖️

Outcome

  • No breach (outwith the scope of the Code).
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training